Effect of fluconazole prophylaxis on the incidence of invasive candida infections and bacteraemias in patients with acute leukaemia

European Journal of Haematology

Volumn 80, Issue 5, 2008, Pages 391-396

  Nihtinen, Anne ^a   Anttila, Veli Jukka ^a   Elonen, Erkki ^a   Juvonen, Eeva ^a   Volin, Liisa ^a   Ruutu, Tapani ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Candida infections; Fluconazole prophylaxis; Leukaemia

Indexed keywords

AMPHOTERICIN B; AMSACRINE; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FLUCONAZOLE; GEMTUZUMAB OZOGAMICIN; IDARUBICIN; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; TIOGUANINE; VINCRISTINE;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDIASIS; DRUG EFFICACY; FEMALE; FINLAND; FUNGUS CULTURE; HISTOPATHOLOGY; HUMAN; INCIDENCE; LEUKEMIA REMISSION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; UNIVERSITY HOSPITAL;

ADULT; BACTEREMIA; CANDIDIASIS; FLUCONAZOLE; HUMANS; LEUKEMIA; RETROSPECTIVE STUDIES;

EID: 41849101421     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2008.01041.x     Document Type: Article

References (33)

1. Ribeiro P, Sousa AB, Nunes O, Aveiro F, Fernandes JP, Gouveia J. Candidemia in acute leukemia patients. Support Care Cancer 1997 5 : 249 51.
2. Tortorano AM, Peman J, Bernhardt H, et al. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004 23 : 317 22.
3. Pagano L, Antinori A, Ammassari A, et al. Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes. Eur J Haematol 1999 63 : 77 85.
4. Semelka RC, Kelekis NL, Sallah S, Worawattanakul S, Ascher SM. Hepatosplenic fungal disease: diagnostic accuracy and spectrum of appearances on MR imaging. AJR 1997 169 : 1311 6.
5. Anttila V-J, Elonen E, Nordling S, Sivonen A, Ruutu T, Ruutu P. Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications. Clin Infect Dis 1997 24 : 375 80.
6. Sallah S, Semelka RC, Wehbie R, Sallah W, Nguyen NP, Vos P. Hepatosplenic candidiasis in patients with acute leukaemia. Br J Haematol 1999 106 : 697 701.
7. Chen C-Y, Chen Y-C, Tang J-L, Yao M, Huang S-Y, Tsai W, Chen Y-A, Shen M-C, Wang C-H, Tien H-F. Hepatosplenic fungal infection in patients with acute leukemia in Taiwan: incidence, treatment, and prognosis. Ann Hematol 2003 82 : 93 7.
8. Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H, Shadduck RK, Shea TC, Stiff P, Friedman DJ. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. NEJM 1992 326 : 845 51.
9. Ellis ME, Qadri SMH, Spence D, Halim MA, Ernst P, Clink H, Baillie F, De Vol EB. The effect of fluconazole as prophylaxis for neutropenic patients on the isolation of Candida spp. from surveillance cultures. J Antimicrob Chemother 1994 33 : 1223 8.
10. Alangaden G, Chandrasekar PH, Bailey E, Khaliq Y. Antifungal prophylaxis with low-dose fluconazole during bone marrow transplantation. Bone Marrow Transplant 1994 14 : 919 24.
11. Slavin MA, Osborne B, Adams R, Levenstein MJ, Schoch HG, Feldman AR, Meyers JD, Bowden RA. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective, randomized, double-blind study. J Infect Dis 1995 171 : 1545 52.
12. Marr KA, Seidel K, Slavin MA, Bowden RA, Schoch HG, Flowers MED, Corey L, Boeckh M. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood 2000 96 : 2055 61.
13. Winston DJ, Chandrasekar PH, Lazarus HM, et al. Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. Ann Intern Med 1993 118 : 495 503.
14. Rotstein C, Bow EJ, Laverdiere M, Ioannou S, Carr D, Moghaddam N. Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group. Clin Infect Dis 1999 28 : 331 40.
15. Abbas J, Bodey GP, Hanna HA, Mardani M, Girgawy E, Abi-Said D, Whimbey E, Hachem R, Raad I. Candida krusei fungemia. An escalating serious infection in immunocompromised patients. Arch Intern Med 2000 160 : 2659 64.
16. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997 24 : 1122 8.
17. Schaffner A, Schaffner M. Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias. J Infect Dis 1995 172 : 1035 41.
18. Viscoli C, Paesmans M, Sanz M, Castagnola E, Klastersky J, Martino P, Glauser M. Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients. Clin Infect Dis 2001 32 : 1532 7.
19. Bodey GP, Anaissie EJ, Edwars JE. Definitions of Candida infections. In : Bodey GP, ed. Candidiasis: Pathogenesis, Diagnosis and Treatment. New York : Raven Press, 1993 : 407 8.
20. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002 34 : 7 14.
21. Palva IP, Almqvist A, Elonen E, et al. Value of maintenance therapy with chemotherapy or interferon during remission of acute myeloid leukaemia. Eur J Haematol 1991 47 : 229 33.
22. Elonen E, Almqvist A, Hänninen A, et al. Comparison between four and eight cycles of intensive chemotherapy in adult acute myeloid leukemia: a randomized trial of the Finnish Leukemia Group. Leukemia 1998 12 : 1041 8.
23. Koistinen P, Räty R, Itälä M, et al. Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group. Eur J Haematol 2007 78 : 477 86.
24. Finnish Leukaemia Group. Long-term survival in acute lymphoblastic leukaemia in adults: a prospective study of 51 patients. Eur J Haematol 1992 48 : 75 82.
25. Elonen E, Itälä M, Jantunen E, et al. Intensive chemotherapy of acute lymphoblastic leukaemia (ALL) in adults supported with G-CSF (Lenograstim). A randomised study between early and delayed start of G-CSF. Br J Haematol 1998 102 : 230.
26. Maertens JA, Frère P, Lass-Flörl C, Heinz W, Cornely OA. Primary antifungal prophylaxis in leukaemia patients. Eur J Cancer Suppl 2007 5 : 43 8.
27. Kern W, Behre G, Rudolf T, Kerkhoff A, Grote-Metke A, Eimermacher H, Kubica U, Wörmann B, Buchner T, Hiddeman W. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group. Cancer 1998 83 : 291 301.
28. Sallah S, Wan JY, Nguyen NP, Vos P, Sigounas G. Analysis of factors related to the occurrence of chronic disseminated candidiasis in patients with acute leukemia in a non-bone marrow transplant setting: a follow-up study. Cancer 2001 92 : 1349 53.
29. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. NEJM 1991 325 : 1274 7.
30. Kunova A, Trupl J, Dluholucky S, Galova G, Krcmery V Jr. Use of fluconazole is not associated with a higher incidence of Candida krusei and other non-albicans Candida species. Clin Infect Dis 1995 21 : 226 7.
31. Hope W, Morton A, Eisen DP. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use. J Hosp Infect 2002 50 : 56 65.
32. Palmblad J, Lönnqvist B, Carlsson B. Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: more bacteraemias. J Int Med 1992 231 : 363 70.
33. Jantunen E, Nihtinen A, Volin L, Juvonen E, Parkkali T, Ruutu T, Anttila V-J. Candidaemia in allogeneic stem cell recipients: low risk without fluconazole prophylaxis. Bone Marrow Transplant 2004 34 : 891 5.